Sagimet Biosciences SGMT 深 沪
已收盘 05-08 16:00:00 美东时间
7.71
+0.070
+0.92%
华盛通- 最 高7.78
- 今 开7.65
- 成交量 96.42万股
- 最 低 7.47
- 昨 收 7.64
- 总市值 2.51亿
- 52周最高 11.41
- 市盈率 静 --
- 换手率 2.96%
- 52周最低 3.15
- 委 比 -6.81%
- 总股本 3258.51万
- 历史最高 20.71
- 量 比 0.78
- 振 幅 4.06%
- 历史最低 1.73
- 每 手 1
- 风险率 1.63%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多U.S. RESEARCH ROUNDUP- Applied Materials, Axsome Therapeutics, Onsemi
U.S. RESEARCH ROUNDUP- Applied Materials, Axsome Therapeutics, Onsemi May 5 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Applied Materials, Axsome Therapeutics and Onsemi on Tuesday. HIGHLIGHTS * Applied Materials AMA
05-05 15:07
美股大行评级 | 潜在涨幅85%！SoFi获机构升目标价至49美元；华尔街大行看涨AMD至400美元
今日重点评级关注：Canaccord Genuity：维持Sagimet Biosciences"买入"评级，目标价从28美元升至49美元；HC Wainwright & Co.：维持Fate Therapeutics"买入"评级，目标价从5美元升至7美元
05-05 11:40
Canaccord Genuity Maintains Buy on Sagimet Biosciences, Raises Price Target to $49
Canaccord Genuity analyst Edward Nash maintains Sagimet Biosciences (NASDAQ:SGMT) with a Buy and raises the price target from $28 to $49.
05-04 23:25
美股大行评级 | 瑞银：维持Visa"买入"评级！目标价从390美元升至410美元
今日重点评级关注：HC Wainwright & Co.：维持Protara Therapeutics"买入"评级，目标价从23美元升至27美元；BTIG：维持Black Diamond Therapeutic"买入"评级，目标价从10美元升至11美元
04-30 19:24
3 Penny Stocks to Watch Now, 4/28/26
High-Trend International Group ($HTCO), Youxin Technology Limited ($YAAS), and ...
04-29 02:07
美股牛股 | 转型锂资源运输！海纳天成国际飙升近240%；X-Energy上市次日续涨超23%
转型锂资源运输！海纳天成国际飙升近240%；X-Energy上市次日续涨超23%，获亚马逊、ARK等明星机构支持>>
04-28 15:42
Why Is Sagimet Biosciences Stock Trading Higher On Monday?
Sagimet shares surge as Phase 3 acne trial plans and $175M offering fund pipeline through 2028, with technicals showing strong momentum.
04-28 01:48
Suja Life launches IPO roadshow, targets $21–$24 per share
Suja Life (SUJA) on Monday said it has begun the roadshow for its initial public offering of 8,888,889 Class A shares, with a price range of $21 to $24 per share. Of the total shares, 8,688,170 are be...
04-27 19:40
Sagimet Biosciences rockets 30% on pricing $175M equity offering
Clinical-stage biopharmaceutical company Sagimet Biosciences (SGMT) stock price jumped about 30% on Monday pre-market hours as the company priced an underwritten offering of ~29M shares at $6.00 per s...
04-27 19:35
Sagimet Biosciences Prices Underwritten Offering Of 29,166,700 Shares Of Series A Common Stock At $6/Shr For Gross Proceeds Of ~$175M
Sagimet Biosciences Inc. (NASDAQ:SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced the pricing of an underwritten
04-27 19:23
